Calliditas Therapeutics Ab
Calliditas Therapeutics Ab's email is johan.haggblad@pharmalink.se
and
Calliditas Therapeutics Ab's phone number is (468)411-3005
.
Calliditas Therapeutics AB is a specialty pharmaceutical company based in Stockholm, Sweden. It is focused on developing high quality pharmaceutical products for patients with a significant unmet medical need in niche indications, in which Calliditas can partially or completely participate in the commercialization efforts. Calliditas is focused on the development and commercialization of the product candidate Nefecon, a unique two step formulation optimized to combine a time lag effect with a concentrated release of the active substance budesonide, within a designated ta...
read more
Calliditas Therapeutics AB is a specialty pharmaceutical company based in Stockholm, Sweden. It is focused on developing high quality pharmaceutical products for patients with a significant unmet medical need in niche indications, in which Calliditas can partially or completely participate in the commercialization efforts. Calliditas is focused on the development and commercialization of the product candidate Nefecon, a unique two step formulation optimized to combine a time lag effect with a concentrated release of the active substance budesonide, within a designated target area. This patented, locally acting formulation is intended for treatment of patients with the inflammatory renal disease IgA nephropathy (IgAN). Calliditas is running a global Phase 3 study within IgAN and aims to commercialize Nefecon in the United States.
show less
Website | calliditas.se | |
Industry | Pharmaceuticals | |
Location | Stockholm, Stockholm, Sweden | |
Employees | 32 | |
Founded | 2004 |
HQ | Engelbrekts kyrkogata 7B | |
Phone | (468)411-3005 | |
johan.haggblad@pharmalink.se | ||
Funding | 108,195,421 USD | |
Competitors | Walgreens Boots Allia..., Pfizer, Cvs Health, Novartis, Gsk, Bayer, |
Website | calliditas.se | |
Industry | Pharmaceuticals | |
Location | Stockholm, Stockholm, Sweden | |
Employees | 32 | |
Founded | 2004 | |
linkedin.com/company/calliditas-therapeutics-ab | ||
HQ | Engelbrekts kyrkogata 7B | |
Phone | (468)411-3005 | |
johan.haggblad@pharmalink.se | ||
Funding | 108,195,421 USD |
Email Patterns for Calliditas Therapeutics Ab
Top Competitors for Calliditas Therapeutics Ab
Calliditas Therapeutics Ab Questions
Where are Calliditas Therapeutics Ab's headquarters?
Calliditas Therapeutics Ab's headquarters are in Engelbrekts kyrkogata 7B
What is Calliditas Therapeutics Ab's phone number?
Calliditas Therapeutics Ab's phone number is (468)411-3005
What is Calliditas Therapeutics Ab's official website?
Calliditas Therapeutics Ab's website is calliditas.se
How many employees are working in Calliditas Therapeutics Ab right now?
Calliditas Therapeutics Ab has
32 employees.
View the Email and Phone Numbers for all 32 working at Calliditas Therapeutics Ab.
What is Calliditas Therapeutics Ab's industry?
Calliditas Therapeutics Ab's industry is
Pharmaceuticals
Who are Calliditas Therapeutics Ab's top competitors?
Calliditas Therapeutics Ab's top competitors are
Walgreens Boots Alliance
,
Pfizer
,
Cvs Health
,
Novartis
,
Gsk
,
Bayer
What is Calliditas Therapeutics Ab's email address?
Calliditas Therapeutics Ab's email address is johan.haggblad@pharmalink.se
What are Calliditas Therapeutics Ab's categories?
Calliditas Therapeutics Ab's categories are Biotechnology, Medical Device, Pharmaceutical
What is Calliditas Therapeutics Ab's location?
Calliditas Therapeutics Ab's location is
Stockholm, Stockholm, Sweden
When was Calliditas Therapeutics Ab's founded?
Calliditas Therapeutics Ab's founding year is 2004
What is Calliditas Therapeutics Ab's funding?
Calliditas Therapeutics Ab's funding is 108,195,421 USD
What is Calliditas Therapeutics Ab's current status?
Calliditas Therapeutics Ab's current status is ipo
Top Calliditas Therapeutics Ab Employees
President, North America
audell@optonline.net
+1203-912-3526
Non Executive Director
diparks44@yahoo.com
+1970-331-2152
Regional Business Director
thomas.smith@shire.com
+1805-372-3000
Director, Us Market Access Operations
lroach@biologicsinc.com
+1919-546-9810
Chief Executive Officer
renee.lucander@pharmalink.se
+468-411-3005
Head Of Us Sales
davidferraro@yahoo.com
+1732-742-9198
Associate Director, Medical Information
alvina230@hotmail.com
+1718-648-3202